You're signed outSign in or to get full access.
72 Investment Holdings, LLC
72 Investment Holdings, LLC is a subsidiary or affiliated entity managed under the Point72 Asset Management umbrella, headquartered in Stamford, CT, United States. Founded by Steven A. Cohen, the wider firm traces roots back to 2014, though 72 Investment Holdings appears to be a special purpose vehicle differentiated in SEC filings. Point72 currently manages over 2,900 employees globally and provides investment management services primarily to institutional investors and qualified clients, employing deep fundamental research and systematic strategies across asset classes.
Investment Strategy
72 Investment Holdings, LLC primarily invests in public equities, with a concentrated portfolio heavily weighted in biotechnology and healthcare innovation firms. The fund typically focuses on high-conviction positions with rigorous research, often leveraging Point72’s broader investment resources. The top holdings as of Q1 2025 are dominated by biotech companies, suggesting a specialized thematic focus. The approach appears to be opportunistic, seeking outsized returns through concentrated bets backed by fundamental analysis, often paralleling the investment philosophy of the broader Point72 organization.
Latest 13F Filing Activity
72 Investment Holdings, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 6 equity positions with a total 13F market value of $38M. The fund increased holdings in Lenz Therapeutics Inc., Praxis Precision Medicines I, Caribou Biosciences Inc. among other positions. 72 Investment Holdings, LLC reduced exposure to Korro Bio Inc., Turnstone Biologics Corp., Alto Neuroscience Inc. among others.
Top Holdings
Equity Positions (6)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
L LENZ | LENZ THERAPEUTICS INC | 77.84% | $29.8M | 1,017,751 | $21.01 | $29.31 | +$3.7M |
K KRRO | KORRO BIO INC | 9.02% | $3.5M | 276,831 | $47.93 | $12.49 | -$1.4M |
P PRAX | PRAXIS PRECISION MEDICINES I | 7.23% | $2.8M | 65,933 | $22.28 | $42.05 | +$275.6K |
A ANRO | ALTO NEUROSCIENCE INC | 3.83% | $1.5M | 667,778 | $14.56 | $2.20 | +$26.7K |
C CRBU | CARIBOU BIOSCIENCES INC | 1.56% | $597.3K | 474,067 | $23.87 | $1.26 | +$164.5K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more